EcoR1 Capital as of Dec. 31, 2022
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 66 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Prothena Corp SHS (PRTA) | 21.2 | $698M | 12M | 60.25 | |
Sarepta Therapeutics (SRPT) | 11.8 | $389M | 3.0M | 129.58 | |
Apellis Pharmaceuticals (APLS) | 8.2 | $268M | 5.2M | 51.71 | |
Anaptysbio Inc Common (ANAB) | 7.1 | $233M | 7.5M | 30.99 | |
Galapagos Nv Spon Adr (GLPG) | 5.0 | $166M | 3.7M | 44.38 | |
Xencor (XNCR) | 4.2 | $138M | 5.3M | 26.04 | |
Arvinas Ord (ARVN) | 3.3 | $107M | 3.1M | 34.21 | |
Revolution Medicines (RVMD) | 3.2 | $106M | 4.5M | 23.82 | |
Morphic Hldg (MORF) | 3.2 | $106M | 4.0M | 26.75 | |
ACADIA Pharmaceuticals (ACAD) | 2.9 | $95M | 6.0M | 15.92 | |
Springworks Therapeutics (SWTX) | 2.7 | $90M | 3.5M | 26.01 | |
Kura Oncology (KURA) | 2.5 | $82M | 6.6M | 12.41 | |
Zai Lab Adr (ZLAB) | 2.0 | $66M | 2.2M | 30.70 | |
Relay Therapeutics (RLAY) | 1.9 | $62M | 4.2M | 14.94 | |
Zymeworks Del Com Added (ZYME) | 1.8 | $60M | 7.6M | 7.86 | |
Alector (ALEC) | 1.1 | $37M | 4.1M | 9.23 | |
Ngm Biopharmaceuticals | 1.0 | $32M | 6.4M | 5.02 | |
Adicet Bio (ACET) | 1.0 | $32M | 3.6M | 8.94 | |
Edgewise Therapeutics (EWTX) | 1.0 | $31M | 3.5M | 8.94 | |
Tango Therapeutics (TNGX) | 0.9 | $31M | 4.2M | 7.25 | |
Atea Pharmaceuticals (AVIR) | 0.9 | $30M | 6.2M | 4.81 | |
Voyager Therapeutics (VYGR) | 0.9 | $29M | 4.8M | 6.10 | |
Allogene Therapeutics (ALLO) | 0.9 | $28M | 4.5M | 6.29 | |
Dyne Therapeutics (DYN) | 0.8 | $27M | 2.3M | 11.59 | |
Nuvation Bio Com Cl A (NUVB) | 0.8 | $27M | 14M | 1.92 | |
Crinetics Pharmaceuticals In (CRNX) | 0.7 | $24M | 1.3M | 18.30 | |
Oric Pharmaceuticals (ORIC) | 0.6 | $20M | 3.4M | 5.89 | |
Kymera Therapeutics (KYMR) | 0.6 | $20M | 796k | 24.96 | |
Graphite Bio | 0.6 | $19M | 5.7M | 3.32 | |
Janux Therapeutics (JANX) | 0.6 | $19M | 1.4M | 13.17 | |
Chinook Therapeutics | 0.6 | $18M | 690k | 26.20 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $16M | 5.2M | 3.10 | |
Poseida Therapeutics I (PSTX) | 0.4 | $14M | 2.7M | 5.30 | |
Ventyx Biosciences (VTYX) | 0.4 | $13M | 400k | 32.79 | |
Ovid Therapeutics (OVID) | 0.3 | $11M | 6.1M | 1.86 | |
Prime Medicine Com Added (PRME) | 0.3 | $11M | 600k | 18.58 | |
Cullinan Oncology (CGEM) | 0.3 | $11M | 1.0M | 10.55 | |
2seventy Bio Common Stock (TSVT) | 0.3 | $11M | 1.1M | 9.37 | |
Geron Corporation (GERN) | 0.3 | $9.7M | 4.0M | 2.42 | |
Aveo Pharmaceuticals Com New | 0.3 | $9.7M | 651k | 14.95 | |
Bioatla (BCAB) | 0.3 | $9.3M | 1.1M | 8.25 | |
Design Therapeutics (DSGN) | 0.3 | $9.1M | 885k | 10.26 | |
Gracell Biotechnologies Sponsored Ads | 0.2 | $7.7M | 3.3M | 2.30 | |
Macrogenics (MGNX) | 0.2 | $7.5M | 1.1M | 6.71 | |
Immatics SHS (IMTX) | 0.2 | $6.5M | 743k | 8.71 | |
Arcutis Biotherapeutics (ARQT) | 0.2 | $6.1M | 415k | 14.80 | |
Precision Biosciences Ord | 0.2 | $6.0M | 5.0M | 1.19 | |
Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.0M | 400k | 9.98 | |
Selecta Biosciences | 0.1 | $4.0M | 3.5M | 1.13 | |
Praxis Precision Medicines I | 0.1 | $3.8M | 1.6M | 2.38 | |
Aligos Therapeutics | 0.1 | $3.8M | 3.9M | 0.95 | |
Abeona Therapeutics Com New (ABEO) | 0.1 | $3.3M | 1.1M | 3.08 | |
Surface Oncology | 0.1 | $3.2M | 3.9M | 0.82 | |
Erasca (ERAS) | 0.1 | $2.9M | 678k | 4.31 | |
Hookipa Pharma Inc equity | 0.1 | $2.0M | 2.5M | 0.81 | |
Eucrates Biomedical Acqu Cor SHS | 0.1 | $2.0M | 200k | 9.99 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.1 | $1.8M | 963k | 1.92 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.5M | 150k | 10.10 | |
Tempest Therapeutics (TPST) | 0.0 | $1.2M | 1.0M | 1.15 | |
Iteos Therapeutics (ITOS) | 0.0 | $791k | 41k | 19.53 | |
Newamsterdam Pharma Company *w Exp 11/22/202 Added (NAMSW) | 0.0 | $727k | 67k | 10.90 | |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $666k | 67k | 9.99 | |
Kronos Bio (KRON) | 0.0 | $529k | 327k | 1.62 | |
Black Diamond Therapeutics (BDTX) | 0.0 | $508k | 282k | 1.80 | |
Caremax *w Exp 06/08/202 | 0.0 | $365k | 100k | 3.65 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $39k | 67k | 0.58 |